Resources Year All 2019 2018 2017 2016 2015 2014 2013 2012 2010 Go Search Presentation Targeted inhibition of Chromosomal Maintenance Region Protein (CRM1) potently suppresses growth of human neuroblastoma cell line models PDF (1.41 MB) Read MorePaper Prognostic impact and targeting of CRM1 in acute myeloid leukemia External Link Read MorePaper KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia External Link Read MorePaper Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells External Link Read MorePaper Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma External Link Read MorePaper Consensus Induced Fit Docking (cIFD): methodology, validation, and application to thediscovery of novel Crm1 inhibitors External Link Read MorePaper CRM1 Blockade by Selective Inhibitors of Nuclear Export (SINE) attenuates Kidney Cancer Growth External Link Read MorePaper Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia External Link Read MorePresentation Results of a Phase I Dose Escalation Study of the Novel, Oral CRM1 Selective Inhibitor of Nuclear Export (SINE) KPT-335 in Dogs with Spontaneous Non-Hodgkin’s Lymphomas (NHL) ()Presentation Potent anticancer activity against both BRAF-mutant and BRAF wild-type melanoma cell lines using a novel CRM1 nuclear export inhibitor PDF (1.40 MB) Read More Previous 1 … 19 20 21 22 Next